Skip to content

Research and Application of Multimodal Micro-Ultrasound in the Diagnosis of Thyroid Nodules

Research and Application of Multimodal Micro-Ultrasound in the Diagnosis of Thyroid Nodules

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116362
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-08
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid

Interventions

Gold Standard:In the clinical diagnosis and differential diagnosis of thyroid nodules, histopathological examination after surgical resection is regarded as the ultimate gold standard.
Index test:SR CEUS parameters of thyroid nodules (microvessel density, flow velocity, flow direction) + shear wave viscoelastic imaging parameters (elastic modulus, viscous coefficient)

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Ultrasound diagnosis of patients with thyroid space-occupying lesions; (2) Patients who are expected to obtain FNA or surgical pathological results; (3) The patient's age is >=18 years old and =75%); (7) Only one nodule is selected for each patient (if there are multiple nodules expected to be benign, the one with the largest diameter is selected; if there are multiple nodules with different malignant possibilities, the one with the highest malignant possibility is selected; if there are multiple nodules with the same malignant possibility, one of them is randomly selected).

Exclusion criteria

Exclusion criteria: (1) Patients whose nodules have undergone surgical treatment or who have a history of radiation exposure to the head and neck; (2) Patients with abnormal test results of T3, T4 and TSH; (3) Patients with thyroid nodules with a maximum diameter of less than 1 cm or more than 4.0cm; (4) Patients with fluid parts of thyroid nodules greater than 25%; (5) Those without definite pathological results (Bethesda I/III/IV patients who have not undergone surgery are excluded from the group).

Design outcomes

Primary

MeasureTime frame
Accuracy;Sensitivity;Specificity;The area under the receiver operating characteristic curve;Precision rate;

Secondary

MeasureTime frame
False Positive Rate;False Negative Rate;F1 Score;

Countries

China

Contacts

Public ContactZhang Yifeng

Shanghai General Hospital

yifengzhang0108@163.com+86 21 6324 0090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026